Biogen Inc. and Eli Lilly

: BIIB, -4.34% and Eli Lilly & Co, according to Market Watch. LLY, +0.95% , investors sold shares of both companies in early trading Wednesday. Despite what many described as encouraging or expected results from tests on drugs to treat dementia, conducted by Biogen Inc. Shares did recover as the session wore on. Biogen, meanwhile started down more than 3% and stayed down more than 2%, to $399.80 in recent trades. Lilly was off more than 3% at one point in early action, but bounced back and was up in recent action to $85.82. (news.financializer.com). As reported in the news.